摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

喹啉,2-丁基-1,2-二氢- | 123612-50-0

中文名称
喹啉,2-丁基-1,2-二氢-
中文别名
——
英文名称
2-n-butyl-1,2-dihydroquinoline
英文别名
2-Butyl-1,2-dihydroquinoline
喹啉,2-丁基-1,2-二氢-化学式
CAS
123612-50-0
化学式
C13H17N
mdl
——
分子量
187.285
InChiKey
KQRMRAPLFTXHFF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    14
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    12
  • 氢给体数:
    1
  • 氢受体数:
    1

SDS

SDS:a5fe1247acead6a7bc7ef9eaabc9610a
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    喹啉,2-丁基-1,2-二氢-sodium 作用下, 以 乙醇 为溶剂, 反应 2.0h, 以96%的产率得到2-butyl-1,2,3,4-tetrahydroquinoline
    参考文献:
    名称:
    2-Substituted 1,2,3,4-Tetrahydroquinolines from Quinoline
    摘要:
    将各种有机金属试剂添加到喹啉中,仅发生在杂环芳香环的2位。由此得到的2-取代的1,2-二氢喹啉随后可在乙醇中用钠轻松还原为1,2,3,4-四氢喹啉。喹啉转化为2-取代的1,2,3,4-四氢喹啉的总体过程,相较于之前文献条件(需要中间的氧化步骤),被发现更为有利。最后一步的产率范围为42-98%,但通常大于80%。
    DOI:
    10.1055/s-1989-27209
  • 作为产物:
    描述:
    喹啉正丁基锂 作用下, 生成 喹啉,2-丁基-1,2-二氢-
    参考文献:
    名称:
    Ziegler; Zeiser, Justus Liebigs Annalen der Chemie, 1931, vol. 485, p. 174,187
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Highly Enantioselective Hydrogenation of Quinolines Using Phosphine-Free Chiral Cationic Ruthenium Catalysts: Scope, Mechanism, and Origin of Enantioselectivity
    作者:Tianli Wang、Lian-Gang Zhuo、Zhiwei Li、Fei Chen、Ziyuan Ding、Yanmei He、Qing-Hua Fan、Junfeng Xiang、Zhi-Xiang Yu、Albert S. C. Chan
    DOI:10.1021/ja2023042
    日期:2011.6.29
    Asymmetric hydrogenation of quinolines catalyzed by chiral cationic η(6)-arene-N-tosylethylenediamine-Ru(II) complexes have been investigated. A wide range of quinoline derivatives, including 2-alkylquinolines, 2-arylquinolines, and 2-functionalized and 2,3-disubstituted quinoline derivatives, were efficiently hydrogenated to give 1,2,3,4-tetrahydroquinolines with up to >99% ee and full conversions
    已经研究了由手性阳离子 η(6)-芳烃-N-甲苯磺酰乙二胺-Ru(II) 配合物催化的喹啉的不对称氢化。广泛的喹啉衍生物,包括 2-烷基喹啉、2-芳基喹啉和 2-官能化和 2,3-二取代的喹啉衍生物,被有效氢化得到 1,2,3,4-四氢喹啉,ee 高达 >99%和完全转换。该催化方案适用于一些具有生物活性的四氢喹啉的克级合成,如 (-)-angustureine 和 6-fluoro-2-methyl-1,2,3,4-tetrahydroquinoline,这是制备的关键中间体抗菌剂(S)-氟甲喹。该反应的催化途径已使用化学计量反应、中间体表征、和同位素标记模式。从这些实验中获得的证据表明,喹啉通过离子和级联反应途径被还原,包括 1,4-氢化物加成、异构化和 1,2-氢化物加成,并且氢加成经历了逐步的 H(+)/H( -) 协调范围之外的转移过程而不是协调机制。此外,DFT 计算表明,对映选择性源自
  • Enantioselective Synthesis of 4-Cyanotetrahydroquinolines via Ni-Catalyzed Hydrocyanation of 1,2-Dihydroquinolines
    作者:Mingdong Jiao、Jihui Gao、Xianjie Fang
    DOI:10.1021/acs.orglett.0c03171
    日期:2020.11.6
    A Ni-catalyzed asymmetric hydrocyanation that enables the formation of 4-cyanotetrahydroquinolines in good yields with excellent enantioselectivities is presented herein. A variety of functional groups are well-tolerated, and a gram-scale reaction supports the synthetic potential of the transformation. Additionally, several crucial intermediates for pharmaceutically active agents, including a PGD2
    本文提出了Ni催化的不对称氢氰化作用,其能够以良好的产率和优异的对映选择性形成4-氰基四氢喹啉。多种官能团的耐受性良好,并且克级反应可支持转化的合成潜力。此外,现在可以使用这种新方案通过不对称合成来获得几种药物活性剂的关键中间体,包括PGD2受体拮抗剂。
  • Bifunctional Borane Catalysis of a Hydride Transfer/Enantioselective [2+2] Cycloaddition Cascade
    作者:Ming Zhang、Xiao‐Chen Wang
    DOI:10.1002/anie.202106168
    日期:2021.7.26
    Herein, we present a mild and efficient method for synthesizing enantioenriched tetrahydroquinoline-fused cyclobutenes through a cascade reaction between 1,2-dihydroquinolines and alkynones with catalysis by chiral spiro-bicyclic bisboranes. The bisboranes served two functions: first they catalyzed a hydride transfer to convert the 1,2-dihydroquinoline substrate to a 1,4-dihydroquinoline, and then
    在此,我们提出了一种温和有效的方法,通过 1,2-二氢喹啉和炔酮之间的级联反应在手性螺双环双硼烷的催化下合成对映体富集的四氢喹啉稠合环丁烯。双硼烷有两个功能:首先它们催化氢化物转移将 1,2-二氢喹啉底物转化为 1,4-二氢喹啉,然后它们激活炔酮底物与 1 进行对映选择性 [2+2] 环加成反应, 4-二氢喹啉原位生成。
  • 10.1002/adsc.202400465
    作者:Zhou, Xiongyang、Li, Xun、Le, Cheng、Li, Jia-Qi
    DOI:10.1002/adsc.202400465
    日期:——
    A domino reaction comprising four consecutive steps based on the strategy of isomerization of allylic alcohols was developed. This base‐catalyzed protocol provided an approach for constructing polysubstituted quinolines without additional additives. A wide range of di‐ or trisubstituted γ‐aminoaryl allylic alcohols bearing alkyl or (hetero)aryl substituents were transformed to the structurally diverse
    基于烯丙醇异构化策略,开发了包含四个连续步骤的多米诺骨牌反应。这种碱催化方案提供了一种无需额外添加剂即可构建多取代喹啉的方法。多种带有烷基或(杂)芳基取代基的二或三取代的γ-氨基芳基烯丙醇被转化为结构多样的喹啉。通过在几种多取代喹啉衍生物(包括天然产物和药物制剂)的简明合成中的应用,证明了这种转化的实用性。初步机理实验表明,γ-氨基芳基烯丙醇的异构化经历了分子内1,3-氢转移,二氢喹啉中间体的芳构化经历了两种可能的途径同时存在,即无受体脱氢和转移氢化过程。
  • Synthesis, Structure-Activity Relationships, and Pharmacological Evaluation of Pyrrolo[3,2,1-ij]quinoline Derivatives: Potent Histamine and Platelet Activating Factor Antagonism and 5-Lipoxygenase Inhibitory Properties. Potential Therapeutic Application in Asthma
    作者:Dominique Paris、Michel Cottin、Patrice Demonchaux、Guy Augert、Pierre Dupassieux、Patrick Lenoir、Michael J. Peck、Daniel Jasserand
    DOI:10.1021/jm00004a013
    日期:1995.2
    A series of pyrrolo[3,2,1-ij]quinoline derivatives was synthesized and evaluated for their in vitro and in vivo activities against histamine, platelet activating factor (PAF), and leukotrienes which are recognized to be of importance in asthma. The structure-activity relationship studies have shown that the optimum moiety on the 1-position of the pyrroloquinoline nucleus is a 2-[4-(4-methyl-2-pyridinyl)-1-piperazinyl]ethyl chain in conjunction with a methyl group on the 2-position for potent antagonism of both histamine and PAF. The introduction of substituents on the 8- and 4-positions was also investigated in order to increase the potency of 5-lipoxygenase inhibition while retaining or improving the activities against histamine and PAF. This series is exemplified by 4-n-butyl-5,6-dihydro-8-hydroxy-2-methyl-1-[2-[4-(4-methyl- 2-pyridinyl)-1-piperazinyl]ethyl]-4H-pyrrolo[3,2,1-ij]quinoline (24, KC 11404) which was found to be active against all three of the selected mediators. Compound 24 was found to be orally active in guinea pig models against the histaminic phase of antigen-induced bronchospasm and PAF-induced bronchoconstriction (ED(50) = 1.9 and 2.1 mu mol/kg, respectively). When tested against the leukotriene-dependent phase of the antigen-induced bronchoconstriction, compound 24 showed the same potency as zileuton.
查看更多